SEARCH

SEARCH BY CITATION

References

  • 1
    Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989; 96:213221.MEDLINE
  • 2
    Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut 1986; 27:10731090.MEDLINE
  • 3
    Matloff DS, Kaplan MM, Neer RM, Goldberg MT, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 1982; 83:97102.MEDLINE
  • 4
    Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblastic function in primary biliary cirrhosis. Ann Intern Med 1985; 103:850860.MEDLINE
  • 5
    Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987; 7:137142.MEDLINE
  • 6
    Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid-treated chronic active hepatitis. Gut 1988; 29:378384.MEDLINE
  • 7
    Olsson R, Johansson C, Lindstedt G, Mellström D. Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 1994; 29:743756.
  • 8
    Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 1991; 6:3943.MEDLINE
  • 9
    Diamond T, Stiel D, Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 1989; 110:430436.MEDLINE
  • 10
    Bikle DD, Genant HK, Cann C, Recker RR, Halloran BP, Strewler GJ. Bone disease in alcohol abuse. Ann Intern Med 1985; 103:4248.MEDLINE
  • 11
    Lalor BC, France MW, Powell D, Adams PH, Couniham TB. Bone and mineral metabolism and chronic alcohol abuse. Q J Med 1986; 59:497511.MEDLINE
  • 12
    Conte D, Caraceni MP, Duriez, Mandelli C, Corghi E, Cesana M, et al. Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 1989; 84:12311234.MEDLINE
  • 13
    Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med 1989; 86:282288.MEDLINE
  • 14
    Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990; 31:8287.MEDLINE
  • 15
    Gonzalez-Calvin JL, García-Sánchez A, Bellot V, Muñoz-Torres M, Raya-Alvarez E, Salvatierra-Rios D. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol 1993; 28:571579.MEDLINE
  • 16
    Laitinen K, Lamberg-Allardt C, Tunninen R, Härkönen M, Välimäki M. Bone mineral density and abstention-induced changes in bone mineral metabolism in noncirrhotic male alcoholics. Am J Med 1992; 93:642650.MEDLINE
  • 17
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding of oesophageal varices. Br J Surg 1973; 60:646649.MEDLINE
  • 18
    Vidal Puig A, Muñoz-Torres M, Escobar-Jiménez F, Ruiz-Requena ME, Garcia Calvente M, Torres-Vela E. Dehydroepyandrosterone sulfate and the other possible influencing factors that module sex hormone–binding globuline levels in the hirsute patient. J Steroid Biochem 1992; 42:607611.
  • 19
    Delmas P, Gineyts E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslinks excretion in normal adults and in Paget's disease. J Bone Miner Res 1993; 5:643649.
  • 20
    Díaz Curiel M, Castro N. Bone mineral density in the Spanish population measured by dual X-ray absorptiometry (DEXA). Bone Miner 1993; (Suppl):133S.
  • 21
    Muñoz-Torres M, Jódar E, Escobar-Jiménez F, López-Ibarra PJ, Luna JD. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcified Tissue Int 1996; 58:316319.
  • 22
    Jodar E, Muñoz-Torrez M, Escobar-Jimenez F, Quesada M, Luna JD, Olea M. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J Clin Endocr Metab 1996; 82:19891994.
  • 23
    World Health Organization Study Group. Assessment of fracture risk and its application to screening for postmenopauseal osteoporosis. Geneva: World Health Organization Technical Reports Series, 1994:843.
  • 24
    Parfitt AM. Morphologic basis of bone mineral measurements: transient and steady-state effects of treatment in osteoporosis. Miner Electrolyte Metab 1980; 4:273287.
  • 25
    Feitelberg S, Epstein S, Ismail F, Dämanda C. Deranged bone mineral metabolism in chronic alcoholism. Metabolism 1987; 36:332336.
  • 26
    Diamond T, Stiel D, Mason R, Lissner D, Bikle D, Wilson S, Posen S. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocr Metab 1989; 69:12341239.MEDLINE
  • 27
    Jackson JA, Kleerekoper M, Parfitt AM, Sudhaker D, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonodal men with spinal osteoporosis. J Clin Endocr Metab 1987; 65:5358.MEDLINE
  • 28
    Wüster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R. Decreased insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993; 234:249255.MEDLINE
  • 29
    Johannsson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S. Growth hormone dependent insulin like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994; 9:915921.MEDLINE
  • 30
    Santolaria F, González-Gonzalez G, Gonzalez-Reimiers, Martínez-Riera A, Milena A, Rodriguez-Moreno F, Gonzalez-Garcia C. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis. Alcohol Alcohol 1995; 30:703708.MEDLINE
  • 31
    Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin-like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995; 21:680688.MEDLINE
  • 32
    Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, Bolognesi M, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition 1997; 13:185190.MEDLINE
  • 33
    Banard R, Ng KW, Martin TJ, Waters MJ. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 1991; 128:14591464.MEDLINE
  • 34
    Spencer E, Liu C, Si E, Howard G. In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone 1991; 12:2126.MEDLINE
  • 35
    Morrison N, Shine J, Eisman J. 1,25-hydroxyvitamin D responsive element and glucocorticoid repression of the osteocalcin gene. Science 1990; 246:115161.
  • 36
    Canalis E, Lian JB. Effects of bone-associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 1988; 9:243246.MEDLINE
  • 37
    Pietschmann P, Resch H, Muller C, Woloszczuk W, Willvonseder R. Decreased serum osteocalcin levels in patients with liver cirrhosis. Bone Miner 1989; 8:103108.
  • 38
    Nielsen HK, Lundby L, Rasmussen K, Peder C, Hansen C. Alcohol decreases serum osteocalcin in a dose dependent way in normal subjects. Calcified Tissue Int 1990; 46:173178.
  • 39
    Garcia-Sanchez A, Gonzalez-Calvin JL, Diez-Ruiz A, Casals JL, Gallego-Rojo F, Salvatierra D. Effect of acute alcohol ingestion on mineral metabolism and osteoblastic function. Alcohol Alcohol 1995; 30:449453.MEDLINE
  • 40
    Garnero P, Delmas PD. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocr Metab 1993; 77:10461053.MEDLINE
  • 41
    Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1997; 17:333368.
  • 42
    Steinberg KK, Bonkovsky HL, Caudill SP, Bernhardt RK, Hawkins M. Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease. Ann Clin Lab Sci 1991; 21:305314.MEDLINE
  • 43
    Puche RC, Caferra DA, Rosillo I. Bone isoenzyme of serum alkaline phosphatase measured with wheat-germ agglutinin. Clin Chem 1988; 34:13721375.MEDLINE
  • 44
    Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH, Hessov I. Osteopenia and osteomalacia after gastrectomy. Interrelations between biochemical markers of bone remodeling, vitamin-D metabolites, and bone histomorphometry. Gut 1991; 32:13031307.MEDLINE
  • 45
    Linde A, Robins SP. Quantitative assessment of collagen crosslinks in dissected predentine and dentine. Collagen Relat Res 1988; 8:443450.
  • 46
    Eastell R, Hampton L, Colwell A. Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. In: ChristiansenC, OvergaardK, eds. Osteoporosis. Copenhagen: Osteopress, 1990;469470.
  • 47
    Ricard-Blum S, Bresson-Hadni S, Vuitton DA, Ville G, Grimaud JA. Hydroxypyridinium collagen cross-links in human liver fibrosis: study on alveolar echinococcosis. Hepatology 1992; 15:599602.MEDLINE
  • 48
    Colwell A, Eastell R, Assiri AMA, Russell RGG. Effect of diet on deoxypyridinoline excretion. In: ChristiansenC, OvergaardK, eds. Osteoporosis. Copenhagen: Osteopress, 1990;590591.
  • 49
    Eriksen EF, Brixen K, Charles P. New markers of bone metabolism: clinical use in metabolic bone disease. Eur J Endocrinol 1995; 132:251263.MEDLINE